GeneDx Appoints Everett Cunningham as New CEO
GeneDx (WGS) has announced the appointment of Everett Cunningham as its new Chief Executive Officer and a member of its board of directors. The transition is scheduled to take effect on or before December 15, 2026. Cunningham will succeed Katherine Stueland, who is stepping down from her role at the company. This leadership change marks a planned succession for the genomic testing provider.

Tickers: $WGS
Topics: Board Membership CEO Appointment Leadership Succession
Read the full article at Seeking Alpha
Part of the story GeneDx Appoints Everett Cunningham as New CEO (5 articles)